Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism
- PMID: 2031869
- DOI: 10.1007/BF00128238
Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism
Abstract
Propionyl-CoA is formed principally during amino acid catabolism. It is then converted chiefly to succinate in a described three-step sequence. Free propionate is formed from propionyl-CoA to a very limited extent, but this anion can participate in a futile cycle of activation and hydrolysis, which can significantly deplete mitochondrial ATP. Free CoA and propionyl-CoA cannot enter or leave mitochondria, but propionyl groups are transferred between separate CoA pools by prior conversion to propionyl-L-carnitine. This reaction requires carnitine and carnitine acetyl transferase, an enzyme abundant in heart tissue. Propionyl-L-carnitine traverses both mitochondrial and cell membranes. Within the cell, this mobility helps to maintain the mitochondrial acyl-CoA/CoA ratio. When this ratio is increased, as in carnitine deficiency states, deleterious consequences ensue, which include deficient metabolism of fatty acids and urea synthesis. From outside the cell (in blood plasma), propionyl-L-carnitine can either be excreted in the urine or redistributed by entering other tissues. This process apparently occurs-without prior hydrolysis and reformation. It is suggested that heart tissue utilizes such exogenous propionyl-L-carnitine to stimulate the tricarboxylic acid cycle (via succinate synthesis) and that this may explain its known protective effect against ischemia.
Similar articles
-
Biochemical profile of propionyl-L-carnitine.Cardiovasc Drugs Ther. 1991 Feb;5 Suppl 1:7-9. doi: 10.1007/BF00128237. Cardiovasc Drugs Ther. 1991. PMID: 2031874
-
L-propionyl-carnitine protection of mitochondria in ischemic rat hearts.Mol Cell Biochem. 1989 Jun 27-Jul 24;88(1-2):169-73. doi: 10.1007/BF00223439. Mol Cell Biochem. 1989. PMID: 2779536
-
Contrasting effects of propionate and propionyl-L-carnitine on energy-linked processes in ischemic hearts.Am J Physiol. 1994 Aug;267(2 Pt 2):H455-61. doi: 10.1152/ajpheart.1994.267.2.H455. Am J Physiol. 1994. PMID: 8067396
-
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.Ann N Y Acad Sci. 2004 Nov;1033:79-91. doi: 10.1196/annals.1320.007. Ann N Y Acad Sci. 2004. PMID: 15591005 Review.
-
Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.Basic Res Cardiol. 2000 Apr;95(2):75-83. doi: 10.1007/s003950050167. Basic Res Cardiol. 2000. PMID: 10826498 Review.
Cited by
-
Medical and nutritional implications in chronic heart failure: strengths and limitations.Arch Cardiol Mex. 2021;91(2):221-228. doi: 10.24875/ACM.20000260. Arch Cardiol Mex. 2021. PMID: 33887757 Free PMC article. English.
-
Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity.PLoS One. 2012;7(3):e34268. doi: 10.1371/journal.pone.0034268. Epub 2012 Mar 23. PLoS One. 2012. PMID: 22457831 Free PMC article.
-
Review of canine dilated cardiomyopathy in the wake of diet-associated concerns.J Anim Sci. 2020 Jun 1;98(6):skaa155. doi: 10.1093/jas/skaa155. J Anim Sci. 2020. PMID: 32542359 Free PMC article. Review.
-
An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.BMC Genomics. 2011 May 20;12:251. doi: 10.1186/1471-2164-12-251. BMC Genomics. 2011. PMID: 21599895 Free PMC article.
-
Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris.J Am Heart Assoc. 2017 Feb 3;6(2):e003620. doi: 10.1161/JAHA.116.003620. J Am Heart Assoc. 2017. PMID: 28159823 Free PMC article.